dc.contributor.author |
Kampa-Schittenhelm, Kerstin Maria |
de_DE |
dc.contributor.author |
Salitzky, Olaf |
de_DE |
dc.contributor.author |
Akmut, Figen |
de_DE |
dc.contributor.author |
Illing, Barbara |
de_DE |
dc.contributor.author |
Kanz, Lothar |
de_DE |
dc.contributor.author |
Salih, Helmut R. |
de_DE |
dc.contributor.author |
Schittenhelm, Marcus Matthias |
de_DE |
dc.date.accessioned |
2022-05-10T07:11:51Z |
|
dc.date.available |
2022-05-10T07:11:51Z |
|
dc.date.issued |
2016 |
de_DE |
dc.identifier.uri |
http://hdl.handle.net/10900/126681 |
|
dc.language.iso |
en |
|
dc.relation.uri |
https://doi.org/10.1186/s12885-015-2029-8 |
de_DE |
dc.title |
Dronabinol has preferential antileukemic activity in acute lymphoblastic and myeloid leukemia with lymphoid differentiation patterns |
de_DE |
dc.type |
Article |
de_DE |
utue.personen.pnd |
Kampa-Schittenhelm, Kerstin Maria/294268154 |
de_DE |
utue.personen.pnd |
Salitzky, Olaf/490008178 |
de_DE |
utue.personen.pnd |
Kanz, Lothar/169791602 |
de_DE |
utue.personen.pnd |
Salih, Helmut Rainer/180103148 |
de_DE |
utue.personen.pnd |
Schittenhelm, Marcus Matthias/186002319 |
de_DE |
utue.publikation.seiten |
25 |
de_DE |
utue.personen.roh |
Kampa-Schittenhelm, Kerstin Maria |
de_DE |
utue.personen.roh |
Salitzky, Olaf |
de_DE |
utue.personen.roh |
Akmut, Figen |
de_DE |
utue.personen.roh |
Illing, Barbara |
de_DE |
utue.personen.roh |
Kanz, Lothar |
de_DE |
utue.personen.roh |
Salih, Helmut Rainer |
de_DE |
utue.personen.roh |
Schittenhelm, Marcus Matthias |
de_DE |
dcterms.isPartOf.ZSTitelID |
BMC cancer - London : BioMed Central |
de_DE |
dcterms.isPartOf.ZS-Volume |
16 |
de_DE |
utue.publikation.seitengesamt |
12 |
de_DE |
utue.titel.verfasserangabe |
Kerstin Maria Kampa-Schittenhelm, Olaf Salitzky, Figen Akmut, Barbara Illing, Lothar Kanz, Helmut Rainer Salih & Marcus Matthias Schittenhelm |
de_DE |
utue.publikation.abrufzeichen |
of04 |
de_DE |
utue.publikation.swbdatum |
2204 |
de_DE |
utue.artikel.ppn |
1801100578 |
de_DE |